Judy Olian Files Form 4 for UTHR; No Transactions Reported
| Field | Detail |
|---|---|
| Company | Olian Judy D. |
| Form Type | 4 |
| Filed Date | Mar 24, 2026 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: insider-filing, no-transaction, form-4
Related Tickers: UTHR
TL;DR
**Insider Judy Olian filed a Form 4 for UTHR, but reported zero transactions.**
AI Summary
On March 23, 2026, Judy D. Olian, a reporting insider, filed a Form 4 indicating no transactions occurred with UNITED THERAPEUTICS Corp (UTHR) securities. This filing, accepted on March 24, 2026, simply confirms her status as an insider without reporting any changes in her beneficial ownership. For investors, this means there's no new insider buying or selling activity to interpret, suggesting a neutral signal regarding the stock from this particular insider at this time.
Why It Matters
This filing confirms an insider's status but reports no change in their holdings, meaning there's no new signal from insider activity for investors to consider.
Risk Assessment
Risk Level: low — This filing indicates no change in beneficial ownership, posing no direct new risk or opportunity.
Analyst Insight
An investor should note that this filing provides no new information regarding insider buying or selling, so it doesn't warrant any immediate action based on insider sentiment.
Key Numbers
- 2026-03-23 — Period of Report (The date for which the ownership status is being reported.)
- 2026-03-24 — Filing Date (The date the Form 4 was submitted to the SEC.)
Key Players & Entities
- Olian Judy D. (person) — Reporting insider
- UNITED THERAPEUTICS Corp (company) — Issuer of securities
- 0001605729 (person) — CIK for Judy D. Olian
- 0001082554 (company) — CIK for UNITED THERAPEUTICS Corp
FAQ
Who is the reporting person in this Form 4 filing?
The reporting person is Olian Judy D., identified by CIK 0001605729.
Which company's securities are the subject of this Form 4 filing?
The securities are those of UNITED THERAPEUTICS Corp, identified by CIK 0001082554.
What was the period of report for this Form 4?
The period of report for this Form 4 was March 23, 2026.
When was this Form 4 filing accepted by the SEC?
This Form 4 filing was accepted by the SEC on March 24, 2026, at 16:31:46.
Does this Form 4 indicate any transactions by Judy D. Olian?
No, the filing details provided do not indicate any transactions; it is a statement of changes in beneficial ownership where no changes are reported.
Filing Stats: 613 words · 2 min read · ~2 pages · Grade level 8.1 · Accepted 2026-03-24 16:31:46
Filing Documents
- primarydocument.html (4)
- primarydocument.xml (4) — 4KB
- 0001605729-26-000006.txt ( ) — 5KB
From the Filing
SEC FORM 4 SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). X Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10. 1. Name and Address of Reporting Person * Olian Judy D. (Last) (First) (Middle) C/O UNITED THERAPEUTICS CORPORATION 1000 SPRING STREET (Street) SILVER SPRING MARYLAND 20910 (City) (State) (Zip) UNITED STATES (Country) 2. Issuer Name and Ticker or Trading Symbol UNITED THERAPEUTICS Corp [ UTHR ] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X Director 10% Owner Officer (give title below) Other (specify below) 2a. Foreign Trading Symbol 3. Date of Earliest Transaction (Month/Day/Year) 03/23/2026 6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person 4. If Amendment, Date of Original Filed (Month/Day/Year) Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 03/23/2026 S (1) 200 D $ 530 4,245 D Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Explanation of Responses: 1. This is a sale of common stock pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on November 4, 2025. Remarks: /s/ John S. Hess, Jr. under Power of Attorney 03/24/2026 ** Signature of Reporting Person Date Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. * If the form is filed by more than one reporting person, see Instruction 4 (b)(v). ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. * Form 4: SEC 1474 (03-26)